11月25日,由临港浦江国际科技城企业思路迪推出的“四项呼吸道病原体核酸检测试剂盒(荧光PCR法)”获国家药品监督管理局批准上市(注册证编号:国械注准20253402375)。值得关注的是,这并非思路迪首次在快速核酸检测领域实现突破。该公司继新冠检测产品首次将临床核酸检测带入30分钟时代后,再次凭借技术创新,将呼吸道多联检的检测速度推向新高度,成功实现30分钟内完成检测的行业领先成果。此次推出的...
Source Link11月25日,由临港浦江国际科技城企业思路迪推出的“四项呼吸道病原体核酸检测试剂盒(荧光PCR法)”获国家药品监督管理局批准上市(注册证编号:国械注准20253402375)。值得关注的是,这并非思路迪首次在快速核酸检测领域实现突破。该公司继新冠检测产品首次将临床核酸检测带入30分钟时代后,再次凭借技术创新,将呼吸道多联检的检测速度推向新高度,成功实现30分钟内完成检测的行业领先成果。此次推出的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.